Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

Eitemau Tebyg

• Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
  gan: Stauder, Reinhard, et al.
  Cyhoeddwyd: (2018)
• Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance
  gan: de Swart, Louise, et al.
  Cyhoeddwyd: (2017)
• Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
  gan: Hoeks, Marlijn, et al.
  Cyhoeddwyd: (2020)
• Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes
  gan: de Swart, Louise, et al.
  Cyhoeddwyd: (2020)
• Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
  gan: Malcovati, Luca, et al.
  Cyhoeddwyd: (2013)